Summary: An interlaboratory study for the radioimmunological determination of calcitonin was performed within the European PTH Study Group (ESPG), tö improve compauability using external quality control. Twelve laboratories determined calcitonin in 21 deep frozen samples using their respective calcitonin radioimmunoassay Systems. The samples included Standard curves of human cäleitonin (sequence 1-32) in serurn äs well äs in assay buffer, several dilutions of a serum fröm a patient with meduUäry thyröid cärcinoma, and additional sera containing calcitonin levels of clmical importarice. For eväluatiori, the known concenträtions were related to the measured values of each laboratory, and of all laboratories together. Except for one, the laboratories recognized the different dilutions used, although absolute values were scattered over a wide ränge. Satisfactory agreement was reached only when the data were calculated äs the percentage of a given value. In future, a serum with a well defmed and constant calcitonin concentration should be used äs an international Standard in all determination of calcitonin by radioimmünoassay.
Introduction
' carcinoma (medullary thyroid carcinoma) and tumours secreting calcitonin ectopically, in renal insufficiency, Elevated calcitonin concentrations in serum have been O r during pregnancy and lactation (1, 2) . With the reported in various clinical conditions such äs C^cell-majority of published radioimmunoassays pathologically elevated values can be measured with accuracy, while A ) Supported by SFB 136 -. Krebsforschung -Project E 3 lev els in the normal ränge remain poorly defined. 2 
) Parathyrin
Moreover absolute values vary considerably (3, 4, 5) .
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For a better comparison of various radioimmunoassay Systems for calcitonin determination, we performed an international collaborative study within the European PTH Study Group. A similar collaborative study was run previously with parathyrin (6) .
The external quality control survey presented here was based on the "Munich Model" (7) (8) (9) . Twelve laboratories participated in the measurement of 21 samples using their routine calcitonin-radioimmunoassays. We collected the data obtained in these laboratories and related the results to the different methods and reagents used. Since we were able to evaluate results of a relatively large number of samples, some of the sources of error could be pinpointed.
Materials and Methods

Test sera
Twenty one samples, each äs two aliquots (in plastic tubes, Eppendorf® reactioh Vials), were sent frozen in dry ice to each participant. The samples, which were randomly numbered (tab. 1), included a six point Standard curve of synthetic human calcitonin (sequence 1-32) (Ciba Geigy) in serum äs well in hormone-free buffer and a zero value. The Standard curve was a geometric dilution of human calcitonin in concentrations ranging from 0.3 to 9.6 Mg/1 dissolved in 0.05 mol/1 barbiturate buffer pH 7.6 containing 50 ml/l of serum from a thyreoidectomized patient and in pooled serum obtained from five normal subjects with undetectable calcitonin levels. Calcitonin was also undetectable in the serum of the thyreoidectomized patient.
Furthermore five dilution Steps were included ranging from l :4 to l :64 of a serum from patient B.F. with medullary thyroid carcinoma diluted in the pooled normal serum, together with another serum pool of medullary thyroid carcinoma patients with high calcitonin levels.
Collaborating laboratories
The twelve collaborating laboratories are listed by code numbers to preserve anonymity.
Radioimmunoassay technique
Technical details of the radioimmunoassays used are listed on I using the chloramine T method according to Hunter & Greenwood (10); specific activities ranged from 2.6-16.7 MBq/Mg. Some laboratories purified the labelled hormone by gel filtration, others by QUSO extraction (11) . äs the Standard, ten Laboratories used synthetic human calcitonin (sequence 1-32) from Ciba Geigy, the other two using products from Armour and Organon, respectively.
All the laboratories performed preincubations in the absence of labelled hormone between eighteen hours and five days. Total incubation times ranged from twenty five hours to eight days. For Separation of the bound from the free hormone ten laboratories used dextran coated charcoal, while two laboratories used polyethyieneglycol. All the laboratories mäde use of homologous Systems with synthetic human calcitonin (sequence l-32).
Results
Figures la-Ib show the results for determination of the two Standard curves (samples 1-^-14 of tab. 1). In each figure the added concentration is plotted on the horizontal axis, the measured calcitonin concentrations on the vertical äxis. The expected correlation between the two sets of corresponding values is defined by a straight line with a slope of 45°. All participating laboratories except for one were able to measure increasing amounts of human calcitonin in the given ränge of 0:3 to 9;6 jug/1-Calcitonin values measured in buffer ( fig. Ife) In order to judge the clinical usefullness of human calcitonin radioimmunoassay we evaluated the ability to differentiate between normal and pathological values using samples 15, 20 and 21 (tab. 1). In figure 3 the reference ränge of all laboratories is indicated together with the results of three sera. The pooled serum from a patient with medullary thyroid carcinoma was expected to show a very high calcitonin level. The serum from patient B.F. with medullary thyroid carcinoma diluted l :64 should have had a concentration near the upper limit of the reference raBge, and the serum of the thyreoidectomized patient was practically calcitonin free. In the 12 laboratories the upper limit of the normal ränge varied between 0.05 and l .0 /zg/1, but was close to 0.5 Mg/1 in most, The detection limit, which defmes the lower limit of the reference ränge, was between 0.01 and 0.11 Mg/1, but predominately around 0.1 Mg/1. Eight laboratories detected no calcitonin in the serum of the thyroidectomized patient, while the values measured in the other laboratories were within the reference ränge. Nine laboratories recognized the serum of the medullary thyroid carcinoma patient diluted l :64 äs a pathological value slightly above the normal ränge.
Conclusion
The participating laboratories in the comparative study of the calcitonin determination were able to distinguish between different concentrations of calcitonin, in serum or buffer although the absolute values were scattered over a wide ränge. Possible causes for these differences include the known immunoheterogeneity of circulating calcitonin (12) , different reagents used äs a Standard, tracer and antibodies and differerit times and temperatures üsed for the incubation, and lastly different Separation techniques. Although participants used homologous radioimmunoassay Systems and only one labpratory encountered technical problems with the radioimmunoassay, the wide scatter of individual values determined for one given concentration meant that absolute values could not be used for comparison of immunoassay results. A reaspnable agreement was reached however, when the data were calculated äs a factor of a given value. We conclude that a Standard with a defined calcitonin concentration should be used by all laboratories äs an internal Standard in every assäy. This Standard should be diluted in pooled serum äs well äs in buffer. We suggest that this Standard might be the international reference preparation for calcitonin of the National Institute for Biological Standards and Control, which has been recently tested in a comparative study of in vitro bioassays (13) . Since this comparative study focussed on pathologically elevated levells, the reference ränge was not defined. For clinical purposes it is most important however to differeiitiate between normal and slightly elevated calcitonin concentrations, for example in order to detect patients with medullary thyroid carcinoma. Therefore subsequent comparative studies are necessary to defme the reference ränge.
